243 related articles for article (PubMed ID: 18558364)
1. Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia.
Perotti M; Ghidoli N; Altara R; Diotti RA; Clementi N; De Marco D; Sassi M; Clementi M; Burioni R; Mancini N
Autoimmun Rev; 2008 Jun; 7(6):468-72. PubMed ID: 18558364
[TBL] [Abstract][Full Text] [Related]
2. Detailed analysis of the E2-IgM complex in hepatitis C-related type II mixed cryoglobulinaemia.
Ferri S; Dal Pero F; Bortoletto G; Bianchi FB; Lenzi M; Alberti A; Gerotto M
J Viral Hepat; 2006 Mar; 13(3):166-76. PubMed ID: 16475992
[TBL] [Abstract][Full Text] [Related]
3. The rheumatoid factor response in the etiology of mixed cryoglobulins associated with hepatitis C virus infection.
Sasso EH
Ann Med Interne (Paris); 2000 Feb; 151(1):30-40. PubMed ID: 10761560
[TBL] [Abstract][Full Text] [Related]
4. Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: relationship to antibody response against hypervariable region genome.
Aiyama T; Yoshioka K; Okumura A; Takayanagi M; Iwata K; Ishikawa T; Kakumu S
Hepatology; 1996 Dec; 24(6):1346-50. PubMed ID: 8938159
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus infection and cryoglobulinaemia.
Lunel F; Musset L
Forum (Genova); 1998; 8(1):95-103. PubMed ID: 9514994
[TBL] [Abstract][Full Text] [Related]
6. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy.
Dammacco F; Sansonno D; Piccoli C; Racanelli V; D'Amore FP; Lauletta G
Semin Liver Dis; 2000; 20(2):143-57. PubMed ID: 10946420
[TBL] [Abstract][Full Text] [Related]
7. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
[TBL] [Abstract][Full Text] [Related]
8. HCV-related immunocytoma and type II mixed cryoglobulinemia-associated autoantigens.
Simula MP; Caggiari L; Gloghini A; De Re V
Ann N Y Acad Sci; 2007 Sep; 1110():121-30. PubMed ID: 17911427
[TBL] [Abstract][Full Text] [Related]
9. Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses.
De Re V; De Vita S; Sansonno D; Gasparotto D; Simula MP; Tucci FA; Marzotto A; Fabris M; Gloghini A; Carbone A; Dammacco F; Boiocchi M
Rheumatology (Oxford); 2006 Jun; 45(6):685-93. PubMed ID: 16399842
[TBL] [Abstract][Full Text] [Related]
10. Characterization of antibodies directed against the immunoglobulin light kappa chain variable chain region (VK) of hepatitis C virus-related type-II mixed cryoglobulinemia and B-cell proliferations.
de Re V; Simula MP; Pavan A; Garziera M; Marin D; Dolcetti R; de Vita S; Sansonno D; Geremia S; Toffoli G
Ann N Y Acad Sci; 2009 Sep; 1173():152-60. PubMed ID: 19758144
[TBL] [Abstract][Full Text] [Related]
11. The pathophysiology of HCV induced B-cell clonal disorders.
Landau DA; Saadoun D; Calabrese LH; Cacoub P
Autoimmun Rev; 2007 Sep; 6(8):581-7. PubMed ID: 17854753
[TBL] [Abstract][Full Text] [Related]
12. Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection.
Burioni R; Mancini N; Carletti S; Perotti M; Grieco A; Canducci F; Varaldo PE; Clementi M
Virology; 2004 Oct; 327(2):242-8. PubMed ID: 15351212
[TBL] [Abstract][Full Text] [Related]
13. Cerebral ischemic attack secondary to hepatitis C virus infection.
Cojocaru IM; Cojocaru M; Iacob SA; Burcin C
Rom J Intern Med; 2005; 43(3-4):255-60. PubMed ID: 16812984
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies.
Mancini N; Canducci F; Carletti S; Berardinelli E; Serafini G; Grieco A; Perotti M; Malcangi G; Danieli MG; Varaldo PE; Clementi M; Burioni R
J Biol Regul Homeost Agents; 2003; 17(2):183-7. PubMed ID: 14518720
[TBL] [Abstract][Full Text] [Related]
15. Renal manifestations associated with hepatitis C virus.
Sinico RA; Fornasieri A; D'Amico G
Ann Med Interne (Paris); 2000 Feb; 151(1):41-5. PubMed ID: 10761561
[TBL] [Abstract][Full Text] [Related]
16. Restricted VH3 gene usage in phage-displayed Fab that are selected by intravenous immunoglobulin.
Osei A; Uttenreuther-Fischer MM; Lerch H; Gaedicke G; Fischer P
Arthritis Rheum; 2000 Dec; 43(12):2722-32. PubMed ID: 11145030
[TBL] [Abstract][Full Text] [Related]
17. [Cryoglobulinemia and hepatitis C virus infection].
Garini G; Catellani W; Manganelli P; Buzio C
Recenti Prog Med; 2001 Jan; 92(1):54-62. PubMed ID: 11260973
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis C and immunoglobulin heavy-chain gene rearrangement].
Gasztonyi B; Pár A; Kereskai L; Pajor L; Kiss K; Szeberényi J; Mózsik G
Orv Hetil; 2002 Apr; 143(15):767-70. PubMed ID: 11979995
[TBL] [Abstract][Full Text] [Related]
19. Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein.
Diotti RA; Sautto GA; Solforosi L; Mancini N; Clementi M; Burioni R
New Microbiol; 2012 Oct; 35(4):475-9. PubMed ID: 23109015
[TBL] [Abstract][Full Text] [Related]
20. Clonal expansion and functional exhaustion of monoclonal marginal zone B cells in mixed cryoglobulinemia: the yin and yang of HCV-driven lymphoproliferation and autoimmunity.
Visentini M; Conti V; Cristofoletti C; Lazzeri C; Marrapodi R; Russo G; Casato M; Fiorilli M
Autoimmun Rev; 2013 Jan; 12(3):430-5. PubMed ID: 22940579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
